Nanoviricides Inc (NNVC)
1.42
+0.06
(+4.41%)
USD |
NYAM |
Oct 31, 16:00
1.42
0.00 (0.00%)
After-Hours: 19:51
Nanoviricides Free Cash Flow: -6.472M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
June 30, 2024 | -6.472M |
March 31, 2024 | -6.394M |
December 31, 2023 | -6.203M |
September 30, 2023 | -5.924M |
June 30, 2023 | -5.822M |
March 31, 2023 | -5.794M |
December 31, 2022 | -5.691M |
September 30, 2022 | -6.544M |
June 30, 2022 | -6.216M |
March 31, 2022 | -7.055M |
December 31, 2021 | -6.906M |
September 30, 2021 | -6.930M |
June 30, 2021 | -8.453M |
March 31, 2021 | -7.853M |
December 31, 2020 | -8.705M |
September 30, 2020 | -7.507M |
June 30, 2020 | -6.674M |
March 31, 2020 | -6.643M |
December 31, 2019 | -6.263M |
September 30, 2019 | -7.315M |
June 30, 2019 | -6.877M |
March 31, 2019 | -8.731M |
December 31, 2018 | -8.143M |
September 30, 2018 | -7.430M |
June 30, 2018 | -8.018M |
Date | Value |
---|---|
March 31, 2018 | -5.537M |
December 31, 2017 | -6.255M |
September 30, 2017 | -7.401M |
June 30, 2017 | -8.063M |
March 31, 2017 | -8.441M |
December 31, 2016 | -8.936M |
September 30, 2016 | -7.567M |
June 30, 2016 | -7.306M |
March 31, 2016 | -8.323M |
December 31, 2015 | -8.021M |
September 30, 2015 | -12.70M |
June 30, 2015 | -12.97M |
March 31, 2015 | -13.09M |
December 31, 2014 | -13.87M |
September 30, 2014 | -10.22M |
June 30, 2014 | -11.56M |
March 31, 2014 | -10.37M |
December 31, 2013 | -8.956M |
September 30, 2013 | -8.051M |
June 30, 2013 | -5.798M |
March 31, 2013 | -5.322M |
December 31, 2012 | -5.044M |
September 30, 2012 | -4.916M |
June 30, 2012 | -4.276M |
March 31, 2012 | -4.244M |
Free Cash Flow Range, Past 5 Years
-8.705M
Minimum
Dec 2020
-5.691M
Maximum
Dec 2022
-6.739M
Average
-6.544M
Median
Sep 2022
Free Cash Flow Benchmarks
NovaBay Pharmaceuticals Inc | -3.396M |
Palatin Technologies Inc | -31.50M |
iBio Inc | -18.55M |
Theriva Biologics Inc | -18.01M |
Oragenics Inc | -7.214M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -1.481M |
Cash from Investing (Quarterly) | -0.0982M |
Cash from Financing (Quarterly) | 3.12M |
Free Cash Flow Per Share (Quarterly) | -0.129 |
Free Cash Flow Yield | -38.39% |